← Back to Screener
Greenland Mines Ltd. Common Stock (GRML)
Price$0.43
Favorite Metrics
Price vs S&P 500 (4W)17.86%
Market Capitalization$52.13M
All Metrics
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-0.08
Price vs S&P 500 (YTD)-19.12%
EPS (TTM)$-0.27
10-Day Avg Trading Volume2.68M
EPS Excl Extra (TTM)$-0.27
EPS (Annual)$-0.22
ROI (Annual)-111.50%
Cash / Share (Quarterly)$0.10
ROA (Last FY)-109.99%
EBITD / Share (TTM)$-0.17
Cash Flow / Share (Annual)$-0.08
P/B Ratio5.51x
Net Income / Employee (Annual)$-5,275,800
Net Interest Coverage (TTM)-3.56x
ROA (TTM)-125.99%
EPS Incl Extra (Annual)$-0.22
Current Ratio (Annual)95.02x
Quick Ratio (Quarterly)93.49x
3-Month Avg Trading Volume2.92M
Revenue / Employee (TTM)$0
52-Week High$0.55
EPS Excl Extra (Annual)$-0.22
Quick Ratio (Annual)93.49x
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)95.02x
Revenue / Employee (Annual)$0
Cash / Share (Annual)$0.10
Net Income / Employee (TTM)$-5,275,800
ROE (Last FY)-111.50%
Net Interest Coverage (Annual)-1.98x
EPS Basic Excl Extra (Annual)$-0.22
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$-0.27
ROI (TTM)-130.08%
Revenue / Share (Annual)$0.00
Year-to-Date Return-8.12%
5-Day Price Return-13.24%
EPS Normalized (Annual)$-0.22
Month-to-Date Return-10.70%
EBITD / Share (Annual)$-0.17
LT Debt / Equity (Annual)0.14x
LT Debt / Equity (Quarterly)0.14x
EPS Basic Excl Extra (TTM)$-0.27
Beta-1.21x
Revenue / Share (TTM)$0.00
ROE (TTM)-137.57%
52-Week Low$0.27
Industry Peers — Biological Products(90)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
GRMLGreenland Mines Ltd. Common Stock | — | — | — | — | $0.43 |
| AMGNAmgen Inc | 4.81x | 9.07% | 73.95% | 2.93% | $336.48 |
| GILDGilead Sciences Inc | 5.59x | 3.48% | 79.35% | 133.64% | $133.34 |
| ARGXargenx SE American Depositary Shares | 11.77x | 89.56% | 150.91% | — | $817.44 |
| BIIBBiogen Inc. Common Stock | 2.97x | 2.22% | 75.69% | -18.77% | $200.40 |
| BNTXBioNTech SE American Depositary Share | 7.90x | -11.81% | 82.18% | — | $93.32 |
| MRNAModerna, Inc. Common Stock | 9.43x | -29.97% | 35.01% | — | $53.35 |
| NBIXNeurocrine Biosciences Inc | 5.32x | 21.45% | 98.18% | 2.31% | $154.54 |
| EXELExelixis Inc | 5.35x | 6.85% | 96.39% | 31.10% | $49.52 |
| KRYSKrystal Biotech, Inc. Common Stock | 22.10x | 25.15% | 94.17% | — | $311.19 |
| IBRXImmunityBio, Inc. Common Stock | 74.65x | 668.31% | 99.34% | — | $7.99 |
About
Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.